Letter by Asinger et al Regarding Articles, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower end of the Risk Spectrum"

Richard W. Asinger, Gautam R. Shroff, Charles A. Herzog

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e387-e388
JournalCirculation
Volume134
Issue number18
DOIs
StatePublished - Nov 1 2016

Bibliographical note

Funding Information:
Dr Herzog has equity interest (stock ownership) in Johnson and Johnson and research support from Johnson and Johnson. He also was a consultant for Bristol Myers Squibb, 2015

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Cite this